Microsoft PowerPoint - Main_Combined_Deck.ppt - Maraviroc - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2007-05-01 12:43:35 HIV/AIDS Entry inhibitors Carbamates Maraviroc Antiretroviral drug Viral load HIV Zidovudine Efavirenz Chemistry Organic chemistry Organofluorides		Microsoft PowerPoint - Main_Combined_Deck.ppt Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 386,37 KB Share Document on Facebook

	PDF Document DocID: 17saC - View Document
	2011 Bull, R.A., J. Hyde, J. M. Mackenzie, G.S. Hansman, T. Oka, N. Takeda and P.A. White[removed]Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes. 42:16- DocID: 11sCt - View Document
	Publications 2013 Mark Gorrell Journal Article Diabetes and Non-alcoholic Fatty Liver Disease – A Pathogenic Duo’ Williams, KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM, Endocrine Reviews 2013 Feb;34(1):[removed]B DocID: 11pY5 - View Document
	2010 Bull, R. A., J-S. Eden, W. D. Rawlinson and P. A. White[removed]Rapid Evolution of Pandemic Noroviruses of the GII.4 lineage. PLoS Pathogens. 6: e1000831. Gorry, P.R., A. Ellett, and S.R. Lewin[removed]Maraviroc. I DocID: 10prU - View Document
	Consultation Decision Analytic Protocol to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc DocID: VMeV - View Document